Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Crystalvue Medical Corporation (6527:TWSE), powered by AI.
Crystalvue Medical Corporation is currently trading at $72.00. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Crystalvue Medical Corporation on Alpha Lenz.
View Crystalvue Medical Corporation's valuation metrics on Alpha Lenz.
“Crystalvue Medical Corporation's ROE is 14.9%. Explore profitability and growth together.”
Ask for details →Crystalvue Medical Corporation is a healthcare company specializing in the research, development, manufacturing, and global distribution of advanced ophthalmic diagnostic medical devices. Established in 2009 and headquartered in Taoyuan City, Taiwan, Crystalvue focuses on innovative solutions for eye care, producing devices such as fundus cameras, optical coherence tomography (OCT) systems, tonometers, lens edgers, and related medical instruments. The company's products play a crucial role in clinical diagnostics for eye health and vision care, serving professionals and healthcare institutions worldwide. Crystalvue also provides original design manufacturing (ODM) and original equipment manufacturing (OEM) services, supporting both branded and private-label medtech businesses. Certified under international standards like ISO 13485 and Taiwan GMP, Crystalvue emphasizes quality and regulatory compliance, with product certifications spanning the US FDA and European directives. The company has established a strong export footprint, with its self-developed devices sold in over 60 countries, contributing to both healthcare infrastructure and technological progress in ophthalmic medicine. Crystalvue Medical Corporation is recognized for its commitment to continuous innovation, stringent quality control, and supporting the advancement of minimally invasive diagnostic and therapeutic solutions in the global medical technology industry.
“Crystalvue Medical Corporation's ROE is 14.9%. Explore profitability and growth together.”
Ask for details →Crystalvue Medical Corporation (ticker: 6527) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies). It has approximately 109 employees.
The current price is 72 with a P/E ratio of -x and P/B of -x.
ROE is 14.94% and operating margin is 19.07%. Annual revenue is $949M.